DDB2 and head and neck squamous cell carcinoma: Collectively, these data demonstrate that DDB2 plays an important role in cisplatin sensitivity and that genetic or pharmacological inhibition of CUL4A sensitizes HNSCC cells to cisplatin-induced DNA damage and apoptosis.